Fayez Sarofim & Co Acquires 47,858 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Fayez Sarofim & Co lifted its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 4.4% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,131,570 shares of the medical equipment provider's stock after acquiring an additional 47,858 shares during the period. Intuitive Surgical comprises approximately 1.5% of Fayez Sarofim & Co's holdings, making the stock its 23rd largest holding. Fayez Sarofim & Co owned about 0.32% of Intuitive Surgical worth $597,323,000 at the end of the most recent quarter.

Several other large investors have also recently added to or reduced their stakes in the company. Howard Capital Management Group LLC increased its holdings in shares of Intuitive Surgical by 4.5% in the 3rd quarter. Howard Capital Management Group LLC now owns 2,125 shares of the medical equipment provider's stock worth $1,044,000 after acquiring an additional 92 shares during the period. Principal Financial Group Inc. grew its position in Intuitive Surgical by 1.5% in the 3rd quarter. Principal Financial Group Inc. now owns 602,393 shares of the medical equipment provider's stock worth $295,938,000 after purchasing an additional 9,194 shares during the last quarter. World Investment Advisors LLC acquired a new stake in shares of Intuitive Surgical in the third quarter valued at approximately $228,000. Arvest Bank Trust Division bought a new stake in shares of Intuitive Surgical during the third quarter valued at approximately $260,000. Finally, Wilmington Savings Fund Society FSB boosted its position in shares of Intuitive Surgical by 15,322.2% during the third quarter. Wilmington Savings Fund Society FSB now owns 555,661 shares of the medical equipment provider's stock worth $272,980,000 after buying an additional 552,058 shares during the period. 83.64% of the stock is currently owned by institutional investors.

Intuitive Surgical Trading Up 1.3 %

Shares of ISRG traded up $6.46 during midday trading on Friday, hitting $514.59. The stock had a trading volume of 2,015,889 shares, compared to its average volume of 1,612,863. The business has a 50-day simple moving average of $513.65 and a two-hundred day simple moving average of $532.19. The firm has a market cap of $183.29 billion, a P/E ratio of 80.28, a price-to-earnings-growth ratio of 5.85 and a beta of 1.55. Intuitive Surgical, Inc. has a fifty-two week low of $367.39 and a fifty-two week high of $616.00.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its quarterly earnings data on Tuesday, April 22nd. The medical equipment provider reported $1.81 EPS for the quarter, topping analysts' consensus estimates of $1.71 by $0.10. Intuitive Surgical had a net margin of 27.81% and a return on equity of 14.55%. The firm had revenue of $2.25 billion during the quarter, compared to analyst estimates of $2.19 billion. During the same quarter last year, the business posted $1.50 EPS. On average, analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Insider Activity

In related news, EVP Robert Desantis sold 11,545 shares of the firm's stock in a transaction that occurred on Thursday, March 13th. The shares were sold at an average price of $499.22, for a total transaction of $5,763,494.90. Following the completion of the sale, the executive vice president now directly owns 5,224 shares in the company, valued at approximately $2,607,925.28. This trade represents a 68.85 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Amal M. Johnson sold 4,635 shares of the business's stock in a transaction on Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the transaction, the director now owns 12,275 shares in the company, valued at approximately $6,955,015. This represents a 27.41 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 33,754 shares of company stock worth $17,691,621. 0.70% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

Several brokerages have weighed in on ISRG. Citigroup lifted their target price on Intuitive Surgical from $640.00 to $711.00 and gave the company a "buy" rating in a research note on Friday, January 24th. JPMorgan Chase & Co. upped their price objective on shares of Intuitive Surgical from $575.00 to $675.00 and gave the stock an "overweight" rating in a report on Friday, January 24th. Erste Group Bank cut shares of Intuitive Surgical from a "strong-buy" rating to a "hold" rating in a research note on Monday, March 17th. Wells Fargo & Company upped their price target on shares of Intuitive Surgical from $630.00 to $687.00 and gave the stock an "overweight" rating in a research note on Friday, January 24th. Finally, UBS Group raised their price objective on shares of Intuitive Surgical from $500.00 to $560.00 and gave the company a "neutral" rating in a research note on Monday, January 27th. Five investment analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company's stock. According to MarketBeat.com, Intuitive Surgical presently has an average rating of "Moderate Buy" and an average target price of $598.95.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.